OSR Health Reports Nasdaq Hearing Scheduled for Sept 29, 2026
$OSRH · OSR Health, Inc.Research Summary
AI-generated summary of this SEC filing
OSR Health Reports Nasdaq Hearing Scheduled for Sept 29, 2026
What Happened OSR Health, Inc. (OSRH) announced that the Nasdaq Hearings Panel scheduled a hearing on the Company’s appeal of Nasdaq’s delisting determination for September 29, 2026 at 10:00 a.m. Eastern Time. The Company submitted its hearing request on August 25, 2026 and was notified of the hearing date on August 27, 2026. Trading in OSR Health’s securities was suspended effective at the opening of business on August 26, 2026. Because the Company timely requested a hearing, Nasdaq has stayed the filing of a Form 25‑NSE (the formal delisting notice) pending the Panel’s decision, but the trading suspension remains in effect. The Company is preparing a presentation and a plan to regain and sustain compliance with Nasdaq’s continued listing requirements and cautions there is no assurance the Panel will grant continued listing.
Key Details
- Hearing request submitted: August 25, 2026; Nasdaq notified the Company of the hearing on August 27, 2026.
- Hearing scheduled: September 29, 2026 at 10:00 a.m. Eastern Time.
- Trading suspension: Took effect at the opening of business on August 26, 2026; timely hearing request did not stay the suspension.
- Formal delisting stayed: Timely hearing request stayed Nasdaq’s filing of Form 25‑NSE, so formal delisting is pending the Panel’s decision.
Why It Matters
- Trading & liquidity: Because trading was suspended on August 26, holders of OSR Health shares cannot trade on Nasdaq while the suspension remains in effect.
- Listing status unresolved: The Panel’s decision will determine whether OSR Health remains listed or is formally delisted (the Company’s timely hearing request prevented the immediate filing of a formal delisting notice).
- Investor risk and uncertainty: The company is presenting a plan to regain compliance, but it explicitly warns there is no assurance the Panel will allow continued listing—this is a material event investors should monitor closely (keywords: Nasdaq, delisting, trading suspension, listing requirements, compliance).